02500 VENUS MEDTECH-B
Closed Add to PorfolioKey Financial Ratio (Fiscal Year: 12/2024) | |||
Current | 2.22X | Oper Margin | N/A |
---|---|---|---|
LT Debt/Equity | 14.2% | Net Margin | N/A |
Total Debt/Equity | 16.7% | Return on Equity | N/A |
Price/Book | 0.77X | Return on Assets | N/A |
(HKD 4.100) | 2024-12 | 2023-12 | 2022-12 | 2021-12 | 2020-12 |
Net Profit (MHKD) | -759.67 | -794.55 | -1,185.89 | -456.99 | -215.98 |
---|---|---|---|---|---|
Net Profit Growth (%) | +4.4 | +33.0 | -159.5 | -111.6 | +49.3 |
Earnings Per Share (HKD) | -1.735 | -1.815 | -2.708 | -1.042 | -0.528 |
Earnings Per Share Growth (%) | +4.4 | +33.0 | -159.9 | -97.5 | +61.4 |
Dividend Per Share (HKD) | No dividend | No dividend | No dividend | No dividend | No dividend |
P/E* (X) | N/A | N/A | N/A | N/A | N/A |
Yield (%) | N/A | N/A | N/A | N/A | N/A |
Dividend Share (%) | N/A | N/A | N/A | N/A | N/A |
Book NAV (HKD) | 5.332 | 7.257 | 9.172 | 12.607 | 10.706 |
Auditors' Opinion | Unqualified | Unqualified | Unqualified | Unqualified | Unqualified |
Remarks:
1. Unqualified = Not Qualified because the financial statements have been fairly presented in accordance with appropriate accounting standards and companies ordinance.
2. Unqualified # = Not Qualified in respect of fundamental uncertainty because of appropriate disclosures.
3. Qualified = Qualified Opinion in respect of limitation in audit scope and/or disclaimer on view given by financial statements and/or disagreement of accounting treatment and/or adverse opinion.
1. Unqualified = Not Qualified because the financial statements have been fairly presented in accordance with appropriate accounting standards and companies ordinance.
2. Unqualified # = Not Qualified in respect of fundamental uncertainty because of appropriate disclosures.
3. Qualified = Qualified Opinion in respect of limitation in audit scope and/or disclaimer on view given by financial statements and/or disagreement of accounting treatment and/or adverse opinion.
Last Update Time: 2025-09-08 21:40:20
Latest Result
(RMBMn) | 2025-06 | 2024-06 | Chg* (%) | 2023-06 |
Cover Period (mths) | 6 | 6 | NA | 6 |
---|---|---|---|---|
Turnover | 187.137 | 230.72 | -18.9 | 255.61 |
Operating Result | -136.299 | -212.94 | -36.0 | -363.375 |
Associates | -2.265 | -0.641 | +253.4 | -6.964 |
Profit Before Taxation | -138.564 | -213.581 | -35.1 | -370.339 |
Taxation | -3.792 | -4.756 | -20.3 | -4.124 |
Profit /( Loss) After Taxation | -134.772 | -208.825 | -35.5 | -366.215 |
Minority Interests | 0 | -2.338 | -100.0 | -16.027 |
Net Profit | -134.772 | -206.487 | -34.7 | -350.188 |
Earnings Per Share () | -0.3372 | -0.5068 | -33.5 | -0.8630 |
Announcement Date | 2025-08-28 | 2024-08-30 | NA | 2023-08-31 |
* Annualised
Last Update Time: 2025-09-08 21:40:25